- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05462769
Percutaneous Plug-based Arteriotomy Closure Device Use in Minimally Invasive Cardiac Surgery
July 14, 2022 updated by: Magnus Dalén, Karolinska University Hospital
A single-center prospective study.
Patients undergoing minimally invasive cardiac surgery between 2017 and 2022 at the Karolinska University Hospital in Stockholm, Sweden are eligible.
Femoral cannulation was performed percutaneously with planned percutaneous arteriotomy closed using a plug-based arteriotomy closure device (MANTA; Teleflex/Essential Medical, Malvern, PA).
Data regarding preoperative clinical characteristics and operative details were obtained by medical records review.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Anticipated)
600
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Magnus Dalén
- Phone Number: +46 (0) 8 123 700 00
- Email: magnus.dalen@karolinska.se
Study Locations
-
-
-
Stockholm, Sweden
- Recruiting
- Karolinska University Hospital
-
Contact:
- Magnus Dalén, MD, PhD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Patients operated with minimally invasive cardiac surgery between 2017 and 2022 at the Karolinska University Hospital in Stockholm, Sweden, with use of percutaneous femoral cannulation with planned percutaneous arteriotomy closed using a plug-based arteriotomy closure device.
Description
Inclusion Criteria:
- Operated with minimally invasive cardiac surgery between 2017 and 2022 at the Karolinska University Hospital in Stockholm, Sweden, with use of percutaneous femoral cannulation with planned percutaneous arteriotomy closed using a plug-based arteriotomy closure device.
Exclusion Criteria:
- None.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Any vascular groin-related complication
Time Frame: During the first 8 weeks after surgery
|
During the first 8 weeks after surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 1, 2017
Primary Completion (Anticipated)
December 1, 2022
Study Completion (Anticipated)
December 1, 2022
Study Registration Dates
First Submitted
July 14, 2022
First Submitted That Met QC Criteria
July 14, 2022
First Posted (Actual)
July 18, 2022
Study Record Updates
Last Update Posted (Actual)
July 18, 2022
Last Update Submitted That Met QC Criteria
July 14, 2022
Last Verified
July 1, 2022
More Information
Terms related to this study
Other Study ID Numbers
- MANTA continued
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Minimally Invasive Cardiac Surgery
-
Pusan National University Yangsan HospitalCompletedMinimally Invasive Cardiac SurgeryKorea, Republic of
-
Shanghai Zhongshan HospitalUnknownMinimally Invasive Cardiac Surgery
-
University of CalgaryRecruitingMinimally Invasive Cardiac Valvular SurgeryCanada
-
Assiut UniversityUnknownPeriareolar Minimally Invasive Cardiac Surgery
-
Eurosets S.r.l.CompletedCardiac Surgery | Cardiopulmonary Bypass | Heart Surgery | Minimally Invasive Surgical ProceduresItaly
-
Peking University Third HospitalEnrolling by invitationCoronary Artery Bypass, Off-Pump | Minimally Invasive Cardiac SurgeryChina
-
Far Eastern Memorial HospitalCompletedMechanical Ventilation | Hospital Length of Stay | Minimally Invasive Cardiac SurgeryTaiwan
-
Jessa HospitalCompletedScar | Minimally Invasive Cardiac SurgeryBelgium
-
University Hospital, MontpellierCompletedMinimally Invasive SurgeryFrance
-
The Second Hospital of Shandong UniversityCompletedMinimally Invasive Surgery
Clinical Trials on Percutaneous vascular closure
-
Seung-Jung ParkCardioVascular Research Foundation, KoreaWithdrawnHeart Valve Diseases | Valvular Insufficiency | Cardiac ValvesKorea, Republic of
-
Erasmus Medical CenterCompletedAortic Valve StenosisNetherlands
-
University of FloridaAccess Pharmaceuticals, Inc.Completed
-
Irmandade Santa Casa Misericórdia MaríliaCompleted
-
Second Affiliated Hospital, School of Medicine,...The First Affiliated Hospital of Nanchang University; LanZhou University; The... and other collaboratorsCompletedNon-valvular Atrial FibrillationChina
-
Assiut UniversityUnknownCongenital Heart Disease
-
Essential Medical, Inc.CompletedFemoral Arteriotomy ClosureNetherlands, Italy
-
InSeal Medical Ltd.TerminatedPercutaneous Closure of Artery Access SitesGermany
-
Haiyan WangCompleted
-
Essential Medical, Inc.TeleflexTerminated